Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|October 27, 1998
Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancerC J Gilbert, W P Petros, J Vredenburgh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 1999
A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancerJ J Vredenburgh, A Hussein, D Fisher, et al.
Cancer Research|September 1, 1987
Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complementA Haleem, J Kurtzberg, G A Olsen, et al.
Bone Marrow Transplantation|June 1, 1990
Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxinR B Montgomery, J Kurtzberg, A Rhinehardt-Clark, et al.
Archives of Dermatology|June 1, 1988
Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow supportT C Shea, K H Antman, J P Eder, et al.
Bone Marrow Transplantation|April 25, 2006
A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapyJ J Vredenburgh, B Madan, D Coniglio, et al.
Blood|June 1, 1994
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow supportE J Shpall, S M Stemmer, L Hami, et al.
American Journal of Obstetrics and Gynecology|March 11, 1992
Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alphaS Wu, K Rodabaugh, O Martinez-Maza, et al.
The New England Journal of Medicine|April 7, 1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantationS J Brandt, W P Peters, S K Atwater, et al.
Bone Marrow Transplantation|February 2, 1997
A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantationM Elkordy, M Crump, J J Vredenburgh, et al.
Pageof 11